Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Multiparametric ultrasound is a useful non-invasive tool for assessing scalp conditions in alopecia areata patients.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

The BHBS is a valid tool to study cultural norms and breast cancer risk in Black women.

Forensic DNA phenotyping faces challenges due to inconsistent terminology, limited genetic understanding, and debates over technology and models.

The rib-sparing technique in breast reconstruction may lead to more complications without reducing the need for further surgery.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

The EMG-to-force model accurately predicts hip muscle forces during walking.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

The study aims to see if maternal hair cortisol levels during pregnancy relate to adverse childhood experiences.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Vietnamese women with PCOS tend to be younger, have larger waists, higher AMH levels, and more body hair than those without PCOS.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

A new computer tool quickly measures hair thickness differences in people with common types of hair loss.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The authors agree that standardizing how PRP methods are reported could help compare results, but note that the link between PRP's contents and hair growth is unclear, and recommend avoiding split-scalp designs in future trials.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

National data helps improve palliative care by highlighting and addressing inequalities.